Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke


Price: $45.00

Edited by Gary L. Myers
Copyright: 2009
TrimSize: 8.5 x 11
Product ID: 5660

NACB Laboratory Medicine Practice Guidelines
These NACB guidelines discuss utilization of emerging laboratory biomarkers of cardiovascular and stroke risk in a primary prevention setting. The risk factors included are: lipoprotein subclasses and particle concentration, lipoprotein (a), apolipoproteins A-I and B, C reactive protein, fibrinogen, white blood cell count, homocysteine, brain (B-type) natriuretic peptide (BNP) and N-terminal pro B-type natriuretic peptide (NT proBNP), and markers of renal function.